Nova Mentis Life Science Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome. The company was formerly known as Liberty Leaf Holdings Ltd. and changed its name to Nova Mentis Life Science Corp. in June 2020. Nova Mentis Life Science Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Frequently asked questions
What sector does Nova Mentis Life Science Corp (NOVA) operate in?
Nova Mentis Life Science Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Nova Mentis Life Science Corp (NOVA) current stock price?
As of the latest data, Nova Mentis Life Science Corp stock price is CA$0.03, with a previous close of CA$0.03.
What is Nova Mentis Life Science Corp (NOVA) current market capitalization?
Nova Mentis Life Science Corp market cap is approximately 889.91 thousand.
What is Nova Mentis Life Science Corp (NOVA) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.10.
Does Nova Mentis Life Science Corp (NOVA) pay dividends?
No. Nova Mentis Life Science Corp does not pay a dividend.
What is Nova Mentis Life Science Corp (NOVA) beta (volatility) score?
Nova Mentis Life Science Corp has a beta of 0.628, indicating lower volatility than the overall market.